FDA committee set to make recommendation on peanut allergy treatment

New studies show early consumption may prevent peanut allergy, Photo Date: 04/15/2013
By  | 

People suffering from peanut allergies will be paying attention to an FDA committee meeting today.
The agency's Allergenic Products Advisory Committee will be discussing, and making recommendations, on the safety of a new peanut allergy treatment.
The treatment, Palforzia, is designed to help reduce the severity of allergic reactions after accidental exposure in patients between the ages of 4 and 17.
At the start of the trial all patients had a reaction to just a third of a peanut.
But after a year 67% of those on the treatment could tolerate about two peanuts, compared to the 4% who were on placebos.
If approved it would be the first FDA approved drug to treat peanut allergy.
Copyright 2019 NBC News. All rights reserved.



 
Comments are posted from viewers like you and do not always reflect the views of this station. powered by Disqus